Items Tagged ‘Niloy “Jewel” Samadder’
June 28, 2022
Mayo Clinic patient grateful after genetic test leads to unexpected, early detection of colon cancer
By Susan Murphy 
Alejandro Mirazo, 56, never imagined his genetic test results would reveal a hereditary link to cancer, or that his findings would potentially save his life. He had participated in a preemptive DNA research sequencing study for Mayo Clinic’s Center for Individualized Medicine in fall 2021 solely to contribute to medical research. As a Mexican American, he also […]
Tags: Center for Individualized Medicine, colon cancer, genetic testing, genomics, Konstantinos Lazaridis, Niloy "Jewel" Samadder
May 31, 2022
Mayo research using DNA to catch cancer, other medical conditions earlier
What would happen if a certain percentage of serious medical conditions, including cancer diagnoses, were found significantly earlier by studying the entire genome of patients’ DNA? How would their quality of life improve, and how many fewer cancer deaths would there be each year? That’s what a group of Mayo Clinic scientists and clinicians aim […]
Tags: Bijan Borah, breast cancer, Center for Individualized Medicine, Center for the Science of Health Care Delivery, Centers for Disease Control and Prevention, DNA, genome, genomics, health disparities, hereditary cancer, hereditary diseases, hypercholesterolemia
December 28, 2021
By Susan Murphy
A new Mayo Clinic study finds 1 in 6 people with pancreatic cancer harbor inherited genetic mutations. Identifying hereditary gene mutations in pancreatic cancer can help determine individualized treatments and potentially prolong survival, according to new Mayo Clinic Center for Individualized Medicine research. In the study, which was published in Clinical and Translational Gastroenterology, nearly 1 in 6 people diagnosed […]
Tags: Center for Individualized Medicine, genetic testing, genomics, Niloy "Jewel" Samadder, pancreatic cancer
May 25, 2021
Mayo study finds colon cancer driven by hereditary gene mutations in 1 in 6 patients
By Susan Murphy
A new Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next. In the study, published in Clinical Gastroenterology and Hepatology, researchers within the Mayo Clinic Center for Individualized Medicine found 1 in 6 patients with colorectal cancer had an inherited cancer-related gene […]
Tags: cancer research, colon cancer, genetic testing, hereditary cancer, Niloy "Jewel" Samadder
December 2, 2020
Conquering cancer by targeting its genetic abnormalities
By Susan Murphy
Joanne Garnett has harrowing memories of that life-changing day back in 1981. She was a 39-year-old land use planner living in Wyoming when she received a call from her doctor confirming she had uterine cancer. “I was shocked, and it was strange because I didn’t fit any profile for uterine cancer,” Garnett recalls. “I got a […]
Tags: BRCA2, breast cancer, cancer genomics, Center for Individualized Medicine, clinical research, DNA, gene mutation, genetic testing, hereditary cancer, Lynch syndrome, Mayo Clinic Cancer Center, Niloy "Jewel" Samadder
September 30, 2020
By Susan Murphy
Patients with a rare genetic disease called familial adenomatous polyposis, (FAP), often face debilitating challenges. Typically striking in the early teenage years, FAP is characterized by hundreds to thousands of tiny polyps forming in the colon and rectum and leading to a nearly 100% percent likelihood that they will get colon cancer without a life-altering surgery […]
Tags: cancer screening, Center for Individualized Medicine, clinical trials, colon cancer, colon polyp, colorectal cancer, gene mutation, genetic testing, hereditary diseases, Niloy "Jewel" Samadder, rare disease
July 31, 2019
Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment
By Advancing the Science contributor
By Sharon Rosen Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and […]
Tags: breast cancer, cancer, Center for Individualized Medicine, gastrointestinal cancer, genetic testing, hereditary cancer, Mayo Clinic Cancer Center, Mayo Clinic Proceedings, Niloy "Jewel" Samadder, ovarian cancer
March 21, 2019
Colon cancer: a new era in cancer screening and detection
March is Colorectal Cancer Awareness Month, a time to focus on one of the most common and preventable forms of cancer. Mayo Clinic is applying a new genomic lens to colorectal and other cancers to identify which are the types that run in families. The answer to that could open new treatment options and also […]
Tags: cancer genomics, Center for Individualized Medicine, colon cancer, hereditary cancer, Lynch syndrome, Niloy "Jewel" Samadder, precision medicine
September 20, 2018
Gerstner awards boost research into hereditary cancer, Parkinson’s disease
This article originally appeared on the Mayo Clinic Center for Individualized Medicine blog on August 27, 2018 Creating tools to detect cancer at an early stage and advancing research into the genetic links to Parkinson’s disease are focuses of the 2018 Gerstner Family Career Development Awards. This year’s winners are Niloy ‘Jewel’ Samadder, M.D., a […]
Tags: cancer prevention, Center for Individualized Medicine, Fabienne Fiesel, genetic testing, genetics, Mayo Clinic Cancer Center, Niloy "Jewel" Samadder, Parkinson's disease
June 6, 2018
Researchers seeking to identify families at risk for cancer
This article originally appeared on the Center for Individualized Medicine blog on March 13, 2018 Physician-researchers within Mayo Clinic’s Hereditary Cancer Clinic are seeking to usher in a new era of identification and prevention for those with inherited risk of cancer. With support from the Center for Individualized Medicine, they are offering DNA blood testing […]
Tags: Center for Individualized Medicine, colon cancer, DNA testing, Douglas Riegert-Johnson, genetic testing, Mayo Clinic Cancer Center, Niloy "Jewel" Samadder